메뉴 건너뛰기




Volumn 21, Issue 8, 2006, Pages 1269-1275

Erratum: α-Tocopherol and ascorbic acid attenuates the ribavirin induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04378.x);417-2α-Tocopherol and ascorbic acid attenuates the ribavirin-induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients

Author keywords

Fatty acid; Hemolytic anemia; Interferon; Lipid peroxidation; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ALPHA2B INTERFERON; ASCORBIC ACID; HEMOGLOBIN; ICOSAPENTAENOIC ACID; LIPID; RIBAVIRIN;

EID: 33745806249     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04670.x     Document Type: Erratum
Times cited : (13)

References (28)
  • 1
    • 0028998145 scopus 로고
    • Clinical outcomes after transfusion-associated hepatitis C
    • Tong MJ, El-Fara NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 1995; 332: 1463-6.
    • (1995) N. Engl. J. Med. , vol.332 , pp. 1463-1466
    • Tong, M.J.1    El-Fara, N.S.2    Reikes, A.R.3    Co, R.L.4
  • 2
    • 0032585237 scopus 로고    scopus 로고
    • Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
    • Poynard T, Marcellin P, Lee SS et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352: 1426-32.
    • (1998) Lancet , vol.352 , pp. 1426-1432
    • Poynard, T.1    Marcellin, P.2    Lee, S.S.3
  • 3
    • 0032547938 scopus 로고    scopus 로고
    • Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
    • McHutchinson JG, Gordon SC, Schiff ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 1998; 339: 1485-92.
    • (1998) N. Engl. J. Med. , vol.339 , pp. 1485-1492
    • McHutchinson, J.G.1    Gordon, S.C.2    Schiff, E.R.3
  • 4
    • 0032547944 scopus 로고    scopus 로고
    • Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
    • International Hepatitis Interventional Therapy Group
    • Davis GL, Esteban-Mur R, Rustgi V et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N. Engl. J. Med. 1998; 339: 1493-9.
    • (1998) N. Engl. J. Med. , vol.339 , pp. 1493-1499
    • Davis, G.L.1    Esteban-Mur, R.2    Rustgi, V.3
  • 5
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
    • Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-65.
    • (2001) Lancet , vol.358 , pp. 958-965
    • Manns, M.P.1    McHutchison, J.G.2    Gordon, S.C.3
  • 6
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 2002; 347: 975-82.
    • (2002) N. Engl. J. Med. , vol.347 , pp. 975-982
    • Fried, M.W.1    Shiffman, M.L.2    Reddy, K.R.3
  • 7
    • 0036830454 scopus 로고    scopus 로고
    • Side effects of therapy of hepatitis C and their management
    • Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002; 36 (Suppl. 1): S237-S244.
    • (2002) Hepatology , vol.36 , Issue.1 SUPPL.
    • Fried, M.W.1
  • 8
    • 0036788338 scopus 로고    scopus 로고
    • Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
    • McHutchinson JG, Manns M, Patel K et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002; 123: 1061-9.
    • (2002) Gastroenterology , vol.123 , pp. 1061-1069
    • McHutchinson, J.G.1    Manns, M.2    Patel, K.3
  • 9
    • 0025866304 scopus 로고
    • Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid
    • Frei B, Forte TM, Ames BN, Cross CL. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem. J. 1991; 277: 133-8.
    • (1991) Biochem. J. , vol.277 , pp. 133-138
    • Frei, B.1    Forte, T.M.2    Ames, B.N.3    Cross, C.L.4
  • 10
    • 0348230014 scopus 로고
    • Reactive oxygen species and antioxidant vitamins: Mechanism of action
    • Frei B. Reactive oxygen species and antioxidant vitamins: mechanism of action. Am. J. Med. 1994; 97: 5S-13S; 22S-28S.
    • (1994) Am. J. Med. , vol.97
    • Frei, B.1
  • 11
    • 0028895543 scopus 로고
    • Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy
    • Hino K, Okuda M, Konishi T et al. Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy. Dig. Dis. Sci. 1995; 40: 14-20.
    • (1995) Dig. Dis. Sci. , vol.40 , pp. 14-20
    • Hino, K.1    Okuda, M.2    Konishi, T.3
  • 12
    • 0016355004 scopus 로고
    • The preparation of red cell ghosts
    • Fleischer S, Packer L, eds. New York: Academic Press
    • Hanahan DJ, Ekholm JL. The preparation of red cell ghosts. In: Fleischer S, Packer L, eds. Methods in Enzymology, Vol. 31 (Part A). New York: Academic Press, 1974; 168-72.
    • (1974) Methods in Enzymology , vol.31 , Issue.PART A , pp. 168-172
    • Hanahan, D.J.1    Ekholm, J.L.2
  • 13
    • 0030976523 scopus 로고    scopus 로고
    • Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine (lysoPC) in ovarian cancer patients
    • Okita M, Gaudette DC, Mills GB, Holub BJ. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine (lysoPC) in ovarian cancer patients. Int. J. Cancer 1997; 71: 31-4.
    • (1997) Int. J. Cancer , vol.71 , pp. 31-34
    • Okita, M.1    Gaudette, D.C.2    Mills, G.B.3    Holub, B.J.4
  • 14
    • 23044524885 scopus 로고    scopus 로고
    • Green vegetable juice increases polyunsaturated fatty acid of erythrocyte membrane phospholipids in hypercholesterolaemic patients
    • Okita M, Sasagawa T, Kotani M et al. Green vegetable juice increases polyunsaturated fatty acid of erythrocyte membrane phospholipids in hypercholesterolaemic patients. Asia Pac. J. Clin. Nutr. 2000; 9: 309-13.
    • (2000) Asia Pac. J. Clin. Nutr. , vol.9 , pp. 309-313
    • Okita, M.1    Sasagawa, T.2    Kotani, M.3
  • 15
    • 0022893845 scopus 로고
    • Retinol, α-tocopherol, lycopene, and α- and β-carotene simultaneously determined in plasma by isocratic liquid chromatography
    • Milne DB, Borten J. Retinol, α-tocopherol, lycopene, and α- and β-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin. Chem. 1986; 32: 874-6.
    • (1986) Clin. Chem. , vol.32 , pp. 874-876
    • Milne, D.B.1    Borten, J.2
  • 16
    • 0020380220 scopus 로고
    • New method for hemoglobin determination by using sodium lauryl sulfate (SLS)
    • Oshiro I, Takenaka T, Maeda J. New method for hemoglobin determination by using sodium lauryl sulfate (SLS). Clin. Biochem. 1982; 15: 83-8.
    • (1982) Clin. Biochem. , vol.15 , pp. 83-88
    • Oshiro, I.1    Takenaka, T.2    Maeda, J.3
  • 17
    • 0001376443 scopus 로고    scopus 로고
    • Change in the level of vitamin C and lipid peroxidation in tissues of the inherently scorbutic rat during ascorbate deficiency
    • Tokumaru S, Takeshita S, Nakata R et al. Change in the level of vitamin C and lipid peroxidation in tissues of the inherently scorbutic rat during ascorbate deficiency. J. Agric. Food Chem. 1996; 44: 2748-53.
    • (1996) J. Agric. Food Chem. , vol.44 , pp. 2748-2753
    • Tokumaru, S.1    Takeshita, S.2    Nakata, R.3
  • 18
    • 7844238614 scopus 로고    scopus 로고
    • Ribavirin and interferon alfa-2b in chronic hepatitis C: Assessment of possible pharmacokinetics and pharmacodynamic interactions
    • Khakoo S, Glue P, Grellier L et al. Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetics and pharmacodynamic interactions. Br. J. Clin. Pharmacol. 1998; 46: 563-70.
    • (1998) Br. J. Clin. Pharmacol. , vol.46 , pp. 563-570
    • Khakoo, S.1    Glue, P.2    Grellier, L.3
  • 19
    • 0033806292 scopus 로고    scopus 로고
    • Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C
    • Jen JF, Glue P, Gupta S, Zambas D, Hajian G. Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C. Ther. Drug Monit. 2000; 22: 555-65.
    • (2000) Ther. Drug Monit. , vol.22 , pp. 555-565
    • Jen, J.F.1    Glue, P.2    Gupta, S.3    Zambas, D.4    Hajian, G.5
  • 20
    • 18344375635 scopus 로고    scopus 로고
    • Viral dynamics and pharmacokinetics in combination interferon alfa-2b and ribavirin therapy for patients with infected hepatitis C virus of genotype 1b and high pretreatment viral load
    • Tsubota A, Akura N, Suzuki F et al. Viral dynamics and pharmacokinetics in combination interferon alfa-2b and ribavirin therapy for patients with infected hepatitis C virus of genotype 1b and high pretreatment viral load. Intervirology 2002; 45: 33-42.
    • (2002) Intervirology , vol.45 , pp. 33-42
    • Tsubota, A.1    Akura, N.2    Suzuki, F.3
  • 21
    • 1242269919 scopus 로고    scopus 로고
    • Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anemia
    • Lindahl K, Schvarcz R, Bruchfeld A, Stahle L. Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anemia. J. Viral Hepat. 2004; 11: 84-7.
    • (2004) J. Viral Hepat. , vol.11 , pp. 84-87
    • Lindahl, K.1    Schvarcz, R.2    Bruchfeld, A.3    Stahle, L.4
  • 22
    • 1642547082 scopus 로고    scopus 로고
    • Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids
    • Yamada S, Funada T, Shibata N et al. Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids. J. Lipid Res. 2004; 45: 626-34.
    • (2004) J. Lipid Res. , vol.45 , pp. 626-634
    • Yamada, S.1    Funada, T.2    Shibata, N.3
  • 23
    • 22844447076 scopus 로고    scopus 로고
    • In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: Correlation with hepatic steatosis
    • Kitase A, Hino K, Furutani T et al. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis. J. Gastroenterol. 2005; 40: 617-24.
    • (2005) J. Gastroenterol. , vol.40 , pp. 617-624
    • Kitase, A.1    Hino, K.2    Furutani, T.3
  • 24
    • 17544367057 scopus 로고    scopus 로고
    • Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage
    • Franceschi LD, Fattovich G, Turrini F et al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 2000; 31: 997-1004.
    • (2000) Hepatology , vol.31 , pp. 997-1004
    • Franceschi, L.D.1    Fattovich, G.2    Turrini, F.3
  • 25
    • 0020693482 scopus 로고
    • Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects
    • Terano T, Hirai A, Hamazaki T et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 1983; 46: 321-31.
    • (1983) Atherosclerosis , vol.46 , pp. 321-331
    • Terano, T.1    Hirai, A.2    Hamazaki, T.3
  • 26
    • 0034827934 scopus 로고    scopus 로고
    • Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects
    • Mabile L, Piolot A, Boulet L et al. Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects. Am. J. Clin. Nutr. 2001; 74: 449-56.
    • (2001) Am. J. Clin. Nutr. , vol.74 , pp. 449-456
    • Mabile, L.1    Piolot, A.2    Boulet, L.3
  • 27
    • 1542600387 scopus 로고    scopus 로고
    • A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C
    • Ide T, Okamura T, Kumashiro R et al. A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C. Int. J. Mol. Med. 2003; 11: 729-32.
    • (2003) Int. J. Mol. Med. , vol.11 , pp. 729-732
    • Ide, T.1    Okamura, T.2    Kumashiro, R.3
  • 28
    • 0034710608 scopus 로고    scopus 로고
    • Fish oil diet affects on oxidative senescence of red blood cells linked to degeneration of spleen cells in mice
    • Oarada M, Furukawa H, Majima T, Miyazawa T. Fish oil diet affects on oxidative senescence of red blood cells linked to degeneration of spleen cells in mice. Biochim. Biophys. Acta 2000; 1487: 1-14.
    • (2000) Biochim. Biophys. Acta , vol.1487 , pp. 1-14
    • Oarada, M.1    Furukawa, H.2    Majima, T.3    Miyazawa, T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.